Caltagirone SpA (BIT:CALT)
9.84
+0.06 (0.61%)
Last updated: Mar 4, 2026, 1:00 PM CET
Caltagirone SpA Employees
Caltagirone SpA had 3,946 employees as of June 30, 2025. The number of employees increased by 21 or 0.54% since the number was reported on December 31, 2024.
Employees
3,946
Change
21
Growth
0.54%
Revenue / Employee
€561,679
Profits / Employee
€33,545
Market Cap
1.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 3,946 | 21 | 0.54% | 3,946 | 0 |
| Dec 31, 2024 | 3,925 | 176 | 4.69% | 3,823 | 102 |
| Dec 31, 2023 | 3,749 | 18 | 0.48% | 3,749 | 0 |
| Dec 31, 2022 | 3,731 | 11 | 0.30% | 3,731 | 0 |
| Dec 31, 2021 | 3,720 | 17 | 0.46% | 3,720 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Buzzi | 10,483 |
| SOL S.p.A. | 7,412 |
| KME Group | 3,435 |
| Cementir Holding | 3,081 |
| Neodecortech | 397 |
| Magis | 217 |
| Industrie Chimiche Forestali | 150 |
| Vinext | 18 |
Caltagirone SpA News
- 1 year ago - Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm - PRNewsWire
- 1 year ago - Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) - PRNewsWire
- 1 year ago - Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei - PRNewsWire
- 1 year ago - Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Calliditas Interim Report January to June 2024 - PRNewsWire
- 1 year ago - Number of shares and votes in Calliditas Therapeutics - PRNewsWire
- 1 year ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders - Accesswire
- 1 year ago - Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy - PRNewsWire